Advancements in Gene and RNA Editing: Enabling Technologies, Applications, and Future Directions
Gene and RNA editing methods and technologies are emerging as innovative forms of therapy and medicine, offering more efficient implementation compared to traditional pharmaceutical treatments.
First-in-Human Trial of CRISPR-Based Gene Therapy for HIV Demonstrates Safety and Promising Results
The first-in-human trial of a CRISPR-Cas9 gene therapy delivered by adeno-associated virus 9 to target the latent HIV proviral genome showed a promising safety profile and potential efficacy in reducing the HIV reservoir in at least one participant.
低温管理を必要としない新しい治療タンパク質の保管・輸送方法の提案
低コストで低温管理を必要としない治療タンパク質の保管・輸送方法の提案
PLA樹脂に組み込まれた酵素によって自己生分解性プラスチックを実現
PLA樹脂に最適化された酵素を組み込むことで、室温下での迅速な生分解性と堆肥化を実現した。
Engineered Enzyme-Embedded PLA Plastic Designed for Rapid Self-Biodegradation and Home Composting
An engineered enzyme embedded into PLA plastic enables rapid biodegradation and compostability under home conditions, providing a scalable industrial solution to address plastic waste.
식물 유전체 공학을 위한 효율적인 표적 부위 통합을 위한 전이효소 보조 기술
식물 유전체에 새로운 DNA를 특정 위치에 삽입하는 현재 기술은 저빈도이고 오류가 많아 개선된 작물 개발을 위한 유전체 편집 접근을 방해한다. 이 연구는 전이효소의 자연스러운 삽입 능력을 활용하여 프로그래밍 가능한 방식으로 표적 삽입을 달성하는 새로운 유전체 공학 도구를 개발했다.
植物ゲノム工学のための効率的なターゲットサイト統合のためのトランスポゼース支援
トランスポゼースの自然な能力を利用して、プログラム可能なCRISPRヌクレアーゼと融合させることで、植物ゲノムへの配列特異的な挿入を可能にする。
CRISPR: 유전자 편집 기술의 혁명적인 발전
CRISPR는 박테리아의 적응 면역 시스템에서 발견된 혁신적인 유전자 편집 도구로, 염색체 DNA의 특정 부위에서 추가, 삭제 또는 수정을 가능하게 하여 유전학 및 생명 과학 분야에 큰 변화를 가져왔다.
CRISPR: A Groundbreaking Gene-Editing Tool Revolutionizing Scientific Research and Potential Applications
CRISPR is a revolutionary gene-editing tool that enables precise modifications to DNA, transforming scientific research and offering promising applications.
European Medicines Agency Approves Two Novel Therapies: Hemophilia B Gene Therapy and Enzyme Replacement for Congenital Thrombotic Thrombocytopenic Purpura
The European Medicines Agency has granted conditional marketing authorization for Durveqtix, a gene therapy for severe and moderately severe hemophilia B, and Adzynma, an enzyme replacement therapy for congenital thrombotic thrombocytopenic purpura, addressing unmet medical needs in these rare conditions.
© 2024 by Linnk AI